Symbol: |
SPG20
|
Description: |
spastic paraplegia 20 (Troyer syndrome) [Source:HGNC Symbol;Acc:18514]
|
Location: |
Chr13:36875775-36944317[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:75
Gene |
Compound |
Gen_sig |
Exp_pattern |
SPG20 |
NSC 11865 |
0.042 |
Up |
SPG20 |
NSC 119911 |
0.001 |
Up |
SPG20 |
NSC 119915 |
0.027 |
Up |
SPG20 |
Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) |
0.043 |
Up |
SPG20 |
Ethanesulfonic acid, compd. with 5-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy]propyl]carbamoyl]-o-toluenesulfonyl fluoride (1:1) |
0.023 |
Up |
SPG20 |
Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) |
0.039 |
Up |
SPG20 |
1-Acetylthio-1-phenyl-2-nitroethane |
0.047 |
Up |
SPG20 |
1-Azabicyclo[2.2.2]octan-3-one, 2-(4-morpholinylmethyl)- |
0.039 |
Down |
SPG20 |
NSC 168197 |
0.011 |
Up |
SPG20 |
NSC 175296 |
0.035 |
Up |
SPG20 |
1H-Pyrazole-1-ethanol, 4,4'-azoxybis(3,5-dimethyl- |
0.04 |
Down |
SPG20 |
Hydrazinecarbothioamide, 2,2'-(1,5-dimethyl-1,5-pentanediylidene)bis[N-methyl- |
0.001 |
Up |
SPG20 |
NSC 18320 |
0.001 |
Up |
SPG20 |
1,8-Octanediamine, N,N'-di-9-acridinyl- |
0.048 |
Up |
SPG20 |
Chlorazin |
0.004 |
Up |
Expression pattern: Sensitivity / Resistance
Total:5 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:34
Total:3 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:43
Total:3 Current:1
[First] [Prev]  Next Last 
|